دورية أكاديمية

Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine.

التفاصيل البيبلوغرافية
العنوان: Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine.
المؤلفون: Hammer, Scott M.1 smh48@cumc.columbia.edu, Sobieszczyk, Magdalena E.1, Janes, Holly2, Karuna, Shelly T.3, Mulligan, Mark J.4, Grove, Doug2, Koblin, Beryl A.5, Buchbinder, Susan P.6, Keefer, Michael7, Tomaras, Georgia D.8, Frahm, Nicole3, Hural, John3, Anude, Chuka9, Graham, Barney S.10, Enama, Mary E.10, Adams, Elizabeth11, DeJesus, Edwin12, Novak, Richard M.13, Frank, Ian14, Bentley, Carter3
المصدر: New England Journal of Medicine. 11/28/2013, Vol. 369 Issue 22, p2083-2092. 10p. 3 Diagrams, 1 Chart.
مصطلحات موضوعية: *DNA, *RECOMBINANT DNA, *ADENOVIRUSES, *VACCINES, *AIDS vaccines
مستخلص: The article discusses research on safety and efficacy of a DNA prime-recombinant adenovirus type 5 boost (DNA/rAd5) vaccine. It reports brief details of DNA-rAd5 vaccine administration to individuals who are at high risk for HIV type 1 (HIV-1) infection, immunogenicity assays performed, and statistical analysis of data from the Statistical Center for HIV/AIDS Research and Prevention. In conclusion, the vaccine regimen failed to reduce rate of HIV-1 acquisition among the population studied.
قاعدة البيانات: Academic Search Index
الوصف
تدمد:00284793
DOI:10.1056/NEJMoa1310566